Genomic & Biopharma News

New implant technology safely minimizes injections for people with macular degeneration
In a clinical trial of 220 people with “wet” age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for injections in the eyes.
News Medical Life Sciences, 2019-06-14 10:54:18

NHS performance figures reveal a deepening crisis in health service, BMA warns
Responding to the latest NHS performance figures, which show waiting lists growing to the highest levels since records began and cancer patients experiencing record-long waits for treatment, BMA consultants committee chair Dr Rob Harwood said: This latest set of NHS figures show a health service descending into an ever-deepening crisis and closer to a system unfit for purpose.
News Medical Life Sciences, 2019-06-14 10:53:17

Pelican Newspaper: Gene profiling at Ocean Ridge Biosciences to unlock mysteries of the human body
Identifying the markers for pancreatic cancer may have happened here in a 5,400 square foot facility where scientists routinely practice next generation RNA profiling and biomarker discovery. Please read the PDF for more details
ORB Company News, 2016-11-25 18:55:37

AMA adopts new policies aimed at improving health of the nation
The American Medical Association, the premier national physician organization in the country, voted this week to adopt new policies aimed at improving the health of the nation.
News Medical Life Sciences, 2019-06-14 10:52:20

GSK, Uni of California pair up to advance genomic research
The LGR will receive up to $67 million in funding over a five-year period.
PharmaTimes, 2019-06-14 09:21:13

Outdated technology systems still ‘limiting’ UK patient care
Over a third (36%) of respondents’ staff have asked for faster digital technology systems.
PharmaTimes, 2019-06-14 09:18:28

GBT sickle cell trial hits endpoint ahead of NDA filing
Global Blood Therapeutics has shared updated data on the sickle cell disease trial it hopes will secure FDA approval of voxelotor. The proportion of patients who had a greater than 1 g/dL increase in hemoglobin is down on GBT’s prior update but still superior to placebo.
Fierce Biotech, 2019-06-14 09:16:16

FiercePharmaAsia—Hansoh-Hengrui billionaire family; Samsung executive's grilling; Aurobindo plant
The couple behind China's Hansoh and Hengrui is among the biopharma industry's richest; Korean prosecutors grilled a top Samsung executive over accounting case; another Aurobindo plant is cited by the FDA; and more.
Fierce Pharma, 2019-06-14 09:07:03

Rituxan hits endpoints in late-stage skin disease trial
The drug demonstrated superiority to current standard-of-care to CellCept.
PharmaTimes, 2019-06-14 09:06:50

Pelican Newspaper: Gene profiling at Ocean Ridge Biosciences to unlock mysteries of the human body
Identifying the markers for pancreatic cancer may have happened here in a 5,400 square foot facility where scientists routinely practice next generation RNA profiling and biomarker discovery. Please read the PDF for more details
ORB Company News, 2016-11-25 18:55:37

ABPI publishes new guidelines on pharma working with patients
The sourcebook covers six topics, which were identified as areas where further guidance would be of assistance.
PharmaTimes, 2019-06-14 08:59:23